Catalyst Wire Dossier Catalyst Wire Dossier

HRS-9813 Capsule

HRS-9813 · Guangdong Hengrui Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-9813 Capsule, covering 2025-07-08 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects [Phase 1]

See pricing